Shivam Chemicals Ltd

Shivam Chemicals Ltd

₹ 47.2 0.00%
21 Nov - close price
About

Incorporated in 2012, Shivam Chemicals Ltd is in the business of wholesale sale of feed ingredients[1]

Key Points

Business Overview:[1]
SCL manufactures Hydrated Lime (Calcium Hydroxide) and distributes various products like Poultry Feed Supplement (MBM), Di-Calcium Phosphate (Feed Grade), Magnesium Oxide, and Limestone Powder. With a marketing network across India, SCL distributes animal feed products for multiple manufacturers and has supplied over 2.50 lakh metric tons of various products valued at Rs. 750 Crs.

  • Market Cap 80.2 Cr.
  • Current Price 47.2
  • High / Low 63.0 / 45.1
  • Stock P/E 34.9
  • Book Value 20.5
  • Dividend Yield 0.00 %
  • ROCE 13.0 %
  • ROE 13.3 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 32.5 to 40.3 days.
  • Working capital days have increased from 44.4 days to 66.0 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Part of BSE SME IPO

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Mar 2024 Sep 2024
62 74 86
61 73 85
Operating Profit 1 2 1
OPM % 2% 2% 1%
0 0 0
Interest 0 0 0
Depreciation 0 0 0
Profit before tax 1 2 1
Tax % 42% 22% 26%
1 1 1
EPS in Rs 0.48 1.15 0.52
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
79 96 177 157 136 160
78 94 171 151 133 157
Operating Profit 1 2 6 5 3 3
OPM % 2% 2% 4% 3% 2% 2%
0 0 0 0 0 1
Interest 0 0 0 0 0 1
Depreciation 0 0 0 0 0 0
Profit before tax 1 1 6 5 3 3
Tax % 36% 32% 25% 27% 29%
1 1 4 4 2 2
EPS in Rs 20.50 21.75 112.25 93.00 1.62 1.67
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 13%
TTM: -13%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 31%
TTM: -47%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 29%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.40 0.40 0.40 0.40 12 17
Reserves 4 5 10 13 3 18
3 2 5 7 11 14
1 3 8 3 7 2
Total Liabilities 9 10 24 24 34 51
1 0 0 0 1 1
CWIP 0 0 0 0 0 0
Investments 0 0 0 2 2 7
8 9 23 22 32 43
Total Assets 9 10 24 24 34 51

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2 -3 -2 -4
0 -0 -1 -0
-2 3 4 4
Net Cash Flow -0 0 -0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 29 27 29 28 40
Inventory Days 1 0 0 0 0
Days Payable 4 9 15 18
Cash Conversion Cycle 26 19 14 28 22
Working Capital Days 30 25 25 43 66
ROCE % 22% 57% 30% 13%

Shareholding Pattern

Numbers in percentages

Apr 2024Sep 2024
73.00% 73.00%
1.36% 0.00%
25.64% 26.99%
No. of Shareholders 1,242457

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents